Do you want to play a key role in driving the ongoing safety surveillance activities for projects within rare blood disorders in Novo Nordisk? And would you like to be part of one of the most skilled and advanced pharmacovigilance functions in Denmark, setting direction and inspiring a team of highly engaged professionals?
If so, you may be our new Department Manager for the Rare Blood Disorders team in Safety Surveillance.
The position
You will be responsible for leading a team consisting of dedicated safety surveillance advisers with medical and life science background.
It will be your job to:
As manager of the team, you will have a close collaboration with a wide range of stakeholders from e.g. Medical & Science, Regulatory Affairs, Clinical Pharmacology, Non-clinical as well as with other functions within Global Patient Safety. This means that building relationships with important stakeholders, and coaching and developing the people in your team is crucial for success.
Qualifications
To be successful in this role you will need to have:
Documented scientific training (e.g. PhD), experience within rare diseases and/or successful experience with people management will be an additional advantage. You must be fluent in English (both written and spoken).
About the department
Safety Surveillance Rare Blood Disorders is a team within the Director area Safety Surveillance Early Development, Rare Disease & Devices which is part of Global Patient Safety at Novo Nordisk and situated in Søborg, Denmark. In the Rare Blood Disorders team, we are responsible for the surveillance of all safety information for Novo Nordisk’s development projects within rare blood disorders. This includes chairing the cross-functional safety committees, contributing to development of clinical study designs and protocols, and performing integrated safety evaluations and overall risk management for investigational compounds during clinical development.
Working at Novo Nordisk
At Novo Nordisk, we do not wait for change. We drive it. We are a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development, through to manufacturing, marketing and sales – we are all working to move the needle on patient care.
Contact
For further information, please contact Christine Dethlefsen, Senior Director, at [email protected].
Deadline
10 December 2024.
We will review the applications on an ongoing basis, so we encourage you to apply as soon as possible.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.
At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
Husk at skrive i din ansøgning, at du så jobbet hos Ofir